ZILA--test for oral cancer? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZILA--test for oral cancer?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ivan Andrew who wrote (21)	6/12/1996 10:22:00 PM
From: Julio P. Antelo	of 61

What to make of CTM acquisition? Now that ZILA has completed the acquisition of CTM for 644,000 shares what do we make of this? Is this bullish for the future of ZILA? I don't know anything about CTM but I suspect one can safely assume these are astute business people. If they are willing to forego a future revenue stream (7.5% of OraTest revenues) for a bunch of ZILA stock they must think that the future value of that stock is greater than the royalty payments they were to receive. On the other hand, they could turn around right now and sell the stock (unless there is a clause that keeps them from doing that) and walk away with 5 mill plus. I just don't know and I'm still scratching my head over this one. And, by the way, where did that 644,000 shares come from? Treasury stock? New stock? Anybody care to jump in and comment? Julio

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next